Burn debridement. Injury due to collapse of burning building or structure in controlled fire
Conditions
Interventions
Intervention 1: Intervention group 1: Patients received 1.5 micrograms/kg of dexmedetomidine along with 40 ml of 0.25% bupivacaine topically. Intervention 2: Intervention group 2: Patients receive 2 m
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18-60 years ASA Class I or II Inclusion of patients of both sexes Patients with burns requiring debridement No known allergy to the medications used in the study Absence of underlying medical conditions such as cardiovascular disease, diabetes, or hypertension Absence of psychiatric or psychological disorders Absence of peripheral or central neuropathy Consent to participate in the study
Exclusion criteria
Exclusion criteria: Lack of cooperation Death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Initially, one, two, four, six, and 12 hours after debridement. Method of measurement: Visual analog scale of pain.;Sedation. Timepoint: One and two hours after debridement. Method of measurement: Ramssay score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Alireza Kamali
Arak University of Medical Sciences
Outcome results
None listed